The Study
The study was conducted at Far-Eastern Memorial Hospital in Taipei, Taiwan. Patients with K. pneumoniae bacteremia were identifi ed during January 1-December 31, 2007. Identifi cation of K. pneumoniae was based on colony morphologic features and biochemical reactions (11) . Data on time until positive blood culture results were obtained from the automated blood culture system at the hospital. Data for each patient were included only once (at the time of the fi rst detection of bacteremia). Patients <18 years of age and those not admitted to our hospital were excluded. Inactive malignancy was not included as an underlying illness. In-hospital and 14-day mortality rates were assessed. For 225 available bacterial isolates, cps genotyping was performed (10) .
A total of 231 patients with K. pneumoniae bacteremia were observed at the hospital during the study; 225 isolates from 225 patients were used. A total of 133 (59%) of these patients had community-onset bacteremia (bacteremia identifi ed in an emergency department Underlying illness was classifi ed as nonfatal in 75.6% of patients with K1 bacteremia (53.7% of patients with non-K1/K2 bacteremia; OR 2.67, 95% CI 1.22-5.84). A lower percentage of patients with K1 bacteremia had surgery in the previous 3 months (9.8% vs. 30.6%; OR 0.25, 95% CI 0.09-0.73). Patients with K1 bacteremia had lower mean ± SD Pittsburgh bacteremia scores than those with non-K1/K2 bacteremia (2.7 ± 3.1 vs. 4.4 ± 4.7; OR 0.90, 95% CI 0.81-0.99), but the time until a positive blood culture was obtained was not different. K1 serotype was more common in patients with liver abscesses (46.3% vs. 4.1%; OR 20.3, 95% CI 7.31-56.40) and less common in patients with urinary tract infections (UTIs) (4.9% vs. 20.4%; OR 0.20, 95% CI 0.05-0.88). The in-hospital mortality rate for patients with K1 bacteremia was lower that that for patients with non-K1/K2 bacteremia (14.6% vs. 34.7%; OR 0.32, 95% CI 0.13-0.82).
No differences were found in clinical characteristics for patients with K2 bacteremia and those with non-K1/K2 bacteremia except for a higher frequency of liver abscesses in patients with K2 bacteremia (13.5% vs. 4.1%; OR 3.67, 95% CI 1.06-12.8). For patients infected with K54 and K57 serotypes, 1 K57 serotype caused liver abscesses; no abscesses were found in patients infected with a K54 serotype. The in-hospital mortality rate was 50% (4/8) for patients with K54 bacteremia and 53.3% (8/15) for patients with K57 bacteremia.
Patients infected with a K1 serotype had lower mean ± SD Pittsburgh bacteremia scores (2.7 ± 3.1 vs. In our patients, K1 and K2 serotypes were found at similar frequencies (18.2% and 16.4%, respectively), which differs from results of Fung et al., in which the K1 serotype was more common (K1 30.8% and K2 5.1%) (12) . Despite reported virulence of the K1 serotype, it was primarily responsible for community-onset bacteremia in patients with less severe underlying illness and associated with lower mortality rates. Moreover, the K1 serotype is associated with liver abscesses and lower mortality rates (2-7). Liver abscesses were found in 46% of patients with K1 bacteremia, and a K1 serotype was found in 63.3% of patients with liver abscesses.
Conclusions
Management of liver abscesses has improved in Taiwan because of increased physician awareness (13) . Mortality rates for patients with K. pneumoniae bacteremia were lower in patients with UTIs or biliary tract infections (5, 14) , which were less common in patients infected with a K1 serotype. Thus, patient outcomes depend more on underlying conditions and severity of sepsis than on bacterial serotypes (5, 9, 14) .
In our previous study of the interval until a positive blood culture for K. pneumoniae bacteremia was obtained (9), we found that higher Pittsburgh bacteremia scores, a time until a positive blood culture <7 hours, and active malignancy were associated with death. In this study, we found no difference in time until a positive blood culture was obtained for patients infected with different serotypes. This interval for patients infected with K1 serotypes was slightly longer than that for patients infected with K2 and non-K1/K2 serotypes. This fi nding may have resulted from a higher percentage of community-onset infections and liver abscesses and less severe underlying illness in patients infected with a K1 serotype.
Studies investigating K. pneumoniae bacteremia have grouped K1 and K2 serotypes (3, 7) . However, such grouping may be problematic because evidence suggests that the K1 serotype is the major cause of primary liver abscesses (6) . Another report showed that the genetic background of serotype K2 is diversifi ed, and only 1 of the 2 major K2 clones was highly virulent in mice (15) . These fi ndings are consistent with our clinical observations. Differences in symptoms of patients infected with K2 and non-K1/K2 serotypes were minimal, despite slightly more liver abscesses among patients infected with K2 serotypes, which was lower than for patients infected with K1 serotypes. Because of different serotyping methods used (3, 5, 15) , caution is required when interpreting data from various studies.
Despite greater virulence of the K1 serotype, it is predominant in patients with community-onset infections and in those with less severe underlying illness. Although the K1 serotype is the major cause of liver abscesses, it results in a lower mortality rate, which can be attributed to host factors. Dr Liao is an infectious diseases specialist in the Department of Internal Medicine, Far-Eastern Memorial Hospital, Taipei, Taiwan. His research interests are clinical characteristics, epidemiology, and pathogenesis of bacterial infections, particularly methicillin-resistant Staphylococcus aureus and Klebsiella pneumoniae.
